Synthesis and structure–activity relationships of sinenxan A derivatives as multidrug resistance reversal agents

Bioorganic & Medicinal Chemistry Letters
2010.0

Abstract

Two types of sinenxan A derivatives with different side chains at C-5 were synthesized and evaluated for their in vitro multidrug resistant reversal activities. Several derivatives exhibited better activities than the positive control verapamil. The structure-activity relationships of these derivatives suggested that a carbonyl group at C-13 and the length of side chain at C-5 are important for the activity.

Knowledge Graph

Similar Paper

Synthesis and structure–activity relationships of sinenxan A derivatives as multidrug resistance reversal agents
Bioorganic & Medicinal Chemistry Letters 2010.0
Multidrug resistance reversal activity of permethyl ningalin B amide derivatives
Bioorganic & Medicinal Chemistry Letters 2004.0
Synthesis and antimultidrug resistance evaluation of icariin and its derivatives
Bioorganic & Medicinal Chemistry Letters 2009.0
A novel class of highly potent multidrug resistance reversal agents: Disubstituted adamantyl derivatives
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis, Pharmacologic Activity, and Structure-Activity Relationships of a Series of Propafenone-Related Modulators of Multidrug Resistance
Journal of Medicinal Chemistry 1995.0
1-(3,4,5-Trimethoxyphenyl)ethane-1,2-diyl esters, a novel compound class with potent chemoreversal activity
Bioorganic & Medicinal Chemistry Letters 2012.0
Synthesis and structure–activity analysis of novel dihydropyridine derivatives to overcome multidrug resistance
Bioorganic & Medicinal Chemistry Letters 2001.0
Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer
Bioorganic & Medicinal Chemistry Letters 2008.0
Synthesis and Activity against Multidrug Resistance in Chinese Hamster Ovary Cells of New Acridone-4-carboxamides
Journal of Medicinal Chemistry 1995.0
1-[4-(2-Aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines: A novel series of highly potent revertants of P-glycoprotein associated multidrug resistance
Bioorganic & Medicinal Chemistry Letters 2008.0